Growth Metrics

Jazz Pharmaceuticals (JAZZ) EPS (Basic) Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 139.68%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 25.99%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 41.58%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 14.28%
7 Evaxion A 62.56 Bn 62.54 Bn - 58.35%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -2.92%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 45.92%
10 Jazz Pharmaceuticals 14.35 Bn 12.51 Bn 934.80 Mn 63.11%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 63.11%
Dec 31, 2025 42.07%
Sep 30, 2025 148.55%
Jun 30, 2025 -184.24%
Mar 31, 2025 -274.84%
Dec 31, 2024 98.29%
Sep 30, 2024 82.41%
Jun 30, 2024 34.60%
Mar 31, 2024 -28.19%
Dec 31, 2023 -14.38%
Sep 30, 2023 -4.44%
Jun 30, 2023 -7.66%
Mar 31, 2023 33.64%
Dec 31, 2022 -70.30%
Sep 30, 2022 -29.51%
Jun 30, 2022 -50.51%
Mar 31, 2022 -72.80%
Dec 31, 2021 -30.07%
Sep 30, 2021 -32.92%
Jun 30, 2021 -81.65%
Mar 31, 2021 41.03%
Dec 31, 2020 -14.84%
Sep 30, 2020 36.06%
Jun 30, 2020 5.56%
Mar 31, 2020 -58.19%
Dec 31, 2019 -12.42%
Sep 30, 2019 6.50%
Jun 30, 2019 34.71%
Mar 31, 2019 6.31%
Dec 31, 2018 25.84%
Sep 30, 2018 19.98%
Jun 30, 2018 2.04%
Mar 31, 2018 -12.77%
Dec 31, 2017 42.06%
Sep 30, 2017 35.09%
Jun 30, 2017 34.09%
Mar 31, 2017 42.79%
Dec 31, 2016 26.64%
Sep 30, 2016 4.65%
Jun 30, 2016 37.95%
Mar 31, 2016 18.78%
Dec 31, 2015 -26.93%
Sep 30, 2015 35.09%
Jun 30, 2015 44.22%
Mar 31, 2015 31.51%
Dec 31, 2014 15.33%
Sep 30, 2014 -17.65%
Jun 30, 2014 -3.41%
Mar 31, 2014 -70.15%
Dec 31, 2013 13.30%
Sep 30, 2013 19.07%
Jun 30, 2013 -3.85%